DEACONESS MEDICAL CENTER
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $4.7M
- Transactions
- 2,140
- Companies
- 40
- Average per transaction
- $2,217
Who reported the payments
| AstraZeneca | $864,587 |
| Merck | $601,634 |
| Eli Lilly | $434,704 |
| Insulet Corporation | $332,950 |
| Gilead | $266,522 |
| Tandem Diabetes Care, Inc. | $221,000 |
| Novo Nordisk AS | $185,547 |
| Astrazeneca UK Limited | $137,182 |
| Grifols Therapeutics LLC | $132,875 |
| Stryker | $120,212 |
| AbbVie | $89,500 |
| Novavax Inc | $75,190 |
| Boehringer Ingelheim | $68,954 |
| Novocure Inc. | $66,042 |
| Artivion, Inc. | $63,380 |
| Ipsen Bioscience Inc. | $62,944 |
| Daiichi Sankyo Inc. | $62,629 |
| Janssen Research & Development, LLC | $61,314 |
| G1 Therapeutics, Inc. | $61,305 |
| Abbott | $57,672 |
| Amgen | $56,706 |
| Eisai Inc. | $54,149 |
| Heartflow, Inc. | $44,680 |
| Organon | $43,021 |
| Angiodynamics, Inc. | $40,914 |
| Takeda Pharmaceuticals U.S.A., Inc. | $39,107 |
| Biontech SE | $34,323 |
| EMD Serono, Inc. | $32,885 |
| Teva Pharmaceuticals USA, Inc. | $31,701 |
| Smith+Nephew | $29,862 |
| Clovis Oncology, Inc. | $28,401 |
| Sanofi US Services Inc. | $27,003 |
| Intuitive Surgical | $25,364 |
| Beigene USA, Inc. | $22,982 |
| Corcept Therapeutics | $22,605 |
| Grifols Diagnostic Solutions, Inc. | $18,678 |
| Genentech, Inc. | $17,760 |
| Linde Gas & Equipment Inc. | $17,742 |
| Sterilmed, Inc. | $16,097 |
| Contego Medical, Inc | $15,875 |